(Q34038304)

30 July 2017

1 reference

title

Will antioxidants fulfill their expectations for the treatment of Alzheimer disease? (English)

1 reference

30 July 2017

0 references

5

Perry G

1 reference

30 July 2017

Rottkamp CA

1

1 reference

30 July 2017

Nunomura A

2

1 reference

30 July 2017

Hirai K

3

1 reference

30 July 2017

Sayre LM

4

1 reference

30 July 2017

Smith MA

6

1 reference

30 July 2017

publication date

1 July 2000

1 reference

Mechanisms of Ageing and Development

30 July 2017

published in

1 reference

30 July 2017

volume

116

1 reference

30 July 2017

issue

2-3

1 reference

30 July 2017

page(s)

169-179

1 reference

Role of oxidative stress in development of complications in diabetes

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Vitamin E and other antioxidants in neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Prevention of cataract in diabetic rats by aspirin, paracetamol (acetaminophen) and ibuprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

B lymphocytes and neuroinvasion

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin?

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Marked changes in mitochondrial DNA deletion levels in Alzheimer brains

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Assembly of Alzheimer-like filaments from full-length tau protein

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Progressive hyperphosphorylation of neurofilament heavy subunits with aging: possible involvement in the mechanism of neurofilament accumulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Sustained efficacy and safety of idebenone in the treatment of Alzheimer's disease: update on a 2-year double-blind multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Subunit asymmetry in the three-dimensional structure of a human CuZnSOD mutant found in familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Inhibition of NF-kappa B by sodium salicylate and aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Copper, iron and zinc in Alzheimer's disease senile plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

The inhibition of sugar-induced structural alterations in collagen by aspirin and other compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Vitamins and analgesics in the prevention of collagen ageing

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Anti‐inflammatory agents as a therapeutic approach to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Paired helical filaments from Alzheimer disease patients contain cytoskeletal components

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Pyrrole formation from 4-hydroxynonenal and primary amines

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Oxidative damage in Alzheimer's

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Widespread peroxynitrite-mediated damage in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Overexpression of heme oxygenase in neuronal cells, the possible interaction with Tau

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2800%2900124-X

7 January 2021

10.1016/S0047-6374(00)00124-X

Identifiers

DOI

1 reference

30 July 2017

1 reference